Unknown

Dataset Information

0

Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.


ABSTRACT: BACKGROUND:There is increasing evidence questioning the use of warfarin for atrial fibrillation (AF) among older adults with end stage renal disease (ESRD). We assessed the patterns and determinants of warfarin utilization among these patients in the US. METHODS:We assembled a cohort of older adults (age??65) undergoing dialysis with incident AF from July 2007 to November 2011 from the US Renal Data System (USRDS). We used descriptive statistics to characterize warfarin utilization within 30 days of AF discharge, and logistic regression to quantify patient characteristics associated with warfarin initiation. RESULTS:Among 5730 older adults undergoing dialysis with incident AF, 15.5% initiated warfarin. Among 2906 patients with high risk of bleeding, 12.7% initiated warfarin; whereas 14.9% initiated warfarin among 4824 patients with high risk of stroke. After adjustment for patient characteristics, warfarin initiation was lower among patients who were older [odds ratio (OR)?=?0.74 per 10-year increase, 95% confidence interval (CI) 0.66-0.83] and those with a history of diabetes (OR?=?0.75, 95% CI 0.63-0.90), myocardial infarction (OR?=?0.64, 95% CI 0.50-0.80), or bleeding (OR?=?0.63, 95% CI 0.50-0.80). There was no association between sex, race, or dialysis modality and warfarin initiation. Among patients who initiated warfarin, 46.8% discontinued warfarin use after a median treatment length of 8.6 months. CONCLUSION:Despite the unclear benefit and increased bleeding risk of warfarin treatment in patients with ESRD, 1 in 8 older adults undergoing dialysis with incident AF in the US who had high risk of bleeding used warfarin. Changes to warfarin therapy due to discontinuation were common after initiation.

SUBMITTER: Tan J 

PROVIDER: S-EPMC5630519 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.

Tan Jingwen J   Bae Sunjae S   Segal Jodi B JB   Zhu Junya J   Segev Dorry L DL   Alexander G Caleb GC   McAdams-DeMarco Mara M  

Journal of nephrology 20170124 6


<h4>Background</h4>There is increasing evidence questioning the use of warfarin for atrial fibrillation (AF) among older adults with end stage renal disease (ESRD). We assessed the patterns and determinants of warfarin utilization among these patients in the US.<h4>Methods</h4>We assembled a cohort of older adults (age ≥65) undergoing dialysis with incident AF from July 2007 to November 2011 from the US Renal Data System (USRDS). We used descriptive statistics to characterize warfarin utilizatio  ...[more]

Similar Datasets

| S-EPMC7019832 | biostudies-literature
| S-EPMC7136833 | biostudies-literature
| S-EPMC5657430 | biostudies-literature
| S-EPMC7568986 | biostudies-literature
| S-EPMC8031437 | biostudies-literature
| S-EPMC6125774 | biostudies-literature
| S-EPMC4672347 | biostudies-other
| S-EPMC5786651 | biostudies-literature
| S-EPMC8263313 | biostudies-literature
| S-EPMC6169066 | biostudies-literature